gvtcx

NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025

NHS England Published 8 May 2025 Find a Tender
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£68,911,980
Statuscomplete
Category (CPV) 33600000
Deadline14 Feb 2025
Procedureopen
OCIDocds-h6vhtk-04d048

Awards (31)

This procurement was awarded to 31 suppliers. Values shown are per-award; the notice total is £68,911,980.

SupplierValueDateStatus
Accord-UK Ltd shared · · active
Amarox Limited shared · · active
Aspire Pharma Limited shared · · active
B. Braun Medical Limited shared · · active
Bowmed Ibisqus Limited shared · · active
Dr.Reddy's Laboratories (UK) Limited shared · · active
Drugsrus Ltd shared · · active
ennogen healthcare ltd shared · · active
Farmak Pharmaceuticals shared · · active
Fresenius Kabi Limited shared · · active
Grindeks Kalceks UK Ltd shared · · active
hameln pharma ltd shared · · active
JCSH Pharma Ltd shared · · active
Kent Pharma Ltd shared · · active
Luye Pharma Ltd shared · · active
Macleods Pharma UK Limited shared · · active
Martindale Pharma shared · · active
Medreich PLC shared · · active
Mercury Pharmaceuticals Limited shared · · active
Milpharm Ltd/aurobinbdo Primary shared · · active
Morningside Pharmaeuticals shared · · active
Mylan shared · · active
Neon Healthcare Ltd shared · · active
Novumgen Limited shared · · active
Panpharma UK Limited shared · · active
Pfizer Ltd shared · · active
Rosemont Pharmaceuticals Limited shared · · active
Seacross Pharmaceuticals Ltd shared · · active
SVP Pharma Ltd shared · · active
Teva UK Limited shared · · active
Wockhardt UK Limited shared · · active

description

Project title: NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025<br/><br/>Offer reference number: CM/PHG/24/5720<br/><br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. <br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/24/5720/01 – Orals (plus non-parenteral) Products<br/>CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months)<br/>NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months)<br/>LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months)<br/><br/>CM/PHG/24/5720/02 – Hospital Only Products<br/>DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months)<br/>DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months)<br/>DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
15 Jan 2025 Contract notice (F02) Earlier regulations 001382-2025
8 May 2025 Contract award notice (F03) Earlier regulations 019881-2025

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.